Feifan Xie

603 total citations
23 papers, 462 citations indexed

About

Feifan Xie is a scholar working on Molecular Biology, Pharmacology and Spectroscopy. According to data from OpenAlex, Feifan Xie has authored 23 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Pharmacology and 5 papers in Spectroscopy. Recurrent topics in Feifan Xie's work include Analytical Chemistry and Chromatography (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Intraperitoneal and Appendiceal Malignancies (3 papers). Feifan Xie is often cited by papers focused on Analytical Chemistry and Chromatography (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Intraperitoneal and Appendiceal Malignancies (3 papers). Feifan Xie collaborates with scholars based in China, Belgium and Netherlands. Feifan Xie's co-authors include Zeneng Cheng, Pieter Colin, Peng Yu, Jan Van Bocxlaer, An Vermeulen, Guo-Qing Zhang, Wenjie Liu, Fang Tang, Wenhu Zhou and Fan Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Pharmaceutical Research.

In The Last Decade

Feifan Xie

23 papers receiving 458 citations

Peers

Feifan Xie
Comparison fields: 5 of 107
  • Biomedical Engineering 106
  • Molecular Biology 83
  • Pharmacology 81
  • Biomaterials 74
  • Pharmaceutical Science 54
Replace Han Xing with:
Han Xing China
Tina Kauss France
Raj Badhan United Kingdom
Rongwu Xiang China
Xiaoye Li China
Monica Gulati India
Yuntao Jia China
Dominik Selzer Germany
Xiaxia Wu China
K. Geetha India
Han Xing China View profile →
Citations per field, relative to Feifan Xie
Feifan Xie · 1×
Citations per year, relative to Feifan Xie
Feifan Xie · 1×

Countries citing papers authored by Feifan Xie

Since Specialization
Citations

This map shows the geographic impact of Feifan Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifan Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifan Xie more than expected).

Fields of papers citing papers by Feifan Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feifan Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifan Xie. The network helps show where Feifan Xie may publish in the future.

Co-authorship network of co-authors of Feifan Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Feifan Xie. A scholar is included among the top collaborators of Feifan Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feifan Xie. Feifan Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 2
2 69
3 12
4 19
5 26
6 13
7 7
8 16
9 22
10 15
11 24
12 37
13 13
14 3
15 7
16 31
17 75
18 3
19 14
20 4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026